key: cord-0754844-u39tq6ky
authors: Guimarães, Filipa; Winck, João C.
title: COVID-19: ONCE UPON A TIME IN PORTUGAL A brief atlas of ongoing pandemic Portuguese research
date: 2020-06-12
journal: Pulmonology
DOI: 10.1016/j.pulmoe.2020.06.001
sha: ac12554a33ff46f799d77fd547e6305a054e6bdd
doc_id: 754844
cord_uid: u39tq6ky

nan

Once upon a time… … a novel coronavirus was described in China. The new year 2020 had just arrived full of hope and promise. Portugal was preparing to defend its European Football Champion title.

And China was far far away.

Suddenly, something changed. The virus had a name, as did the disease it caused. The cases were spreading fast and arrived in Europe. Now, the threat was real. Portugal was panicking with suspected cases and the scientific community was warning of a lack of preparedness.

And it arrived indeed on March 2 nd .

Then what?

Epidemiologists began to develop mathematical models to predict the epidemic, describing different scenarios 1 . The predicted peak in the number of cases in Portugal could be as high as 2.5 million 1 .

As the days went by, journalists and television commentators were becoming "experts" in epidemiology. Recommendations from health authorities were extensively publicized in the media.

Anticipating the worst-case scenario and keeping an eye on other European countries, the state of emergency was officially declared in Portugal on March 18 th . And, in the name of public health, individual freedom was suspended.

Contingency plans were adopted across the National Health Service and the rule was clear:

only emergencies allowed 2 ! The number of cases began to rise. And the testing capacity was struggling to meet the high demand. Investigators advised that scaling up testing could be cost-saving, since early isolation would lead to prevention of new infections and fewer hospitalizations 3 . Clinical evidence kept growing, and recommendations for intensive care approach to COVID-19 patients were published 5 . Safety of health-care professionals was a major concern, especially regarding aerosol-generating procedures. Non-invasive ventilation and high-flow nasal cannula oxygen therapy were a controversial subject. A literature search found a window of opportunity for those strategies in some non-severe patients 6 .

About all the potential COVID-19 therapies, was there something missing? Potential benefits from a drug widely used in asthmatic patients -Montelukast -, were proposed and are being submitted to investigation in a clinical trial. While waiting for a vaccine, it is important to talk about herd immunity. It's currently believed that herd immunity to SARS-CoV-2 infection requires 60-70% of immune individuals. However, individual variation in biological susceptibility and exposure (heterogeneity of populations) needs to be considered, as it accelerates the acquisition of immunity in populationsthis can reduce the herd immunity threshold to 10-20% 8 .

COVID-19 has dominated our minds over the previous months. But what was left behind?

Many health activities were neglected and an excess mortality was described, 3 to 5 fold higher than can be explained by the official COVID-19 deaths 9 . And this is probably just the tip of the iceberg.

This story ends with the words of a pulmonologist: we must learn how to evolve in the wake of these new Coronaviruses, the nCoVs, to make a sustained and responsible change in our behaviour and attitudes. New citizens, new mankind: 2020-nMan 10 .

After it all ends, let's just hope to live happily ever after. 

Predicting the evolution and control of the COVID-19 pandemic in

Sleep labs, lung function tests and COVID-19 pandemic -Only emergencies allowed!

Is scaling-up COVID-19 testing cost-saving?

Identifying baseline clinical features of people with COVID-19

Sociedade Portuguesa de Cuidados Intensivos and Infection & Sepsis Group for intensive care approach to COVID-19

COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a

An evidence based evaluation of problems

Diversidade genética do novo coronavírus SARS-CoV-2 (COVID-19) em

Ponto de situação 2020

Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold

Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal

And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan